Showing results (51-60 of 78) with videos related to
Sort By:
Pageof 8
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2003
Greater CD8+ TCR heterogeneity and functional flexibility in HIV-2 compared to HIV-1 infectionA Ross Lopes, Assan Jaye, Lucy Dorrell, et al.NPJ Vaccines|September 29, 2021
Specific human cytomegalovirus signature detected in NK cell metabolic changes post vaccinationElena Woods, Vanessa Zaiatz-Bittencourt, Ciaran Bannan, et al.Scientific Reports|December 12, 2019
A multi-genotype therapeutic human papillomavirus vaccine elicits potent T cell responses to conserved regions of early proteinsGemma Hancock, Joshua Blight, Cesar Lopez-Camacho, et al.Journal of the International AIDS Society|May 25, 2017
Evaluation of the immunogenicity and impact on the latent HIV-1 reservoir of a conserved region vaccine, MVA.HIVconsv, in antiretroviral therapy-treated subjectsGemma Hancock, Sara Morón-López, Jakub Kopycinski, et al.Plos Pathogens|February 28, 2015
Identification of effective subdominant anti-HIV-1 CD8+ T cells within entire post-infection and post-vaccination immune responsesGemma Hancock, Hongbing Yang, Elisabeth Yorke, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|October 30, 2013
Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1Nicola Borthwick, Tina Ahmed, Beatrice Ondondo, et al.Journal of Virus Eradication|October 6, 2021
No evidence of neuronal damage as measured by neurofilament light chain in a HIV cure study utilising a kick-and-kill approachJasmini Alagaratnam, Wolfgang Stöhr, Jamie Toombs, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 14, 2024
Instability of the HLA-E peptidome of HIV presents a major barrier to therapeutic targetingZoë Wallace, Tiaan Heunis, Rachel L Paterson, et al.The Journal of General Virology|March 25, 2004
A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humansMatilu Mwau, Inese Cebere, Julian Sutton, et al.European Journal of Immunology|October 16, 2015
Defining the HLA class I-associated viral antigen repertoire from HIV-1-infected human cellsNicola Ternette, Hongbing Yang, Thomas Partridge, et al.Pageof 8